The effect of intra-arterial papaverine on ECoG activity in the ketamine anesthetized rat

Neuroscience Letters

Volumn 445, Issue 1, 2008, Pages 58-61

  Karatas, Ayse ^a   Gokce, Fatih ^a   Demir, Serif ^a   Ankarali, Seyit ^b  

^a DUZCE UNIVERSITY   (Turkey)

^b ZONGULDAK KARAELMAS UNIVERSITY   (Turkey)

Author keywords

Epilepsy; Papaverine; Rat; Subarachnoid hemorrhage; Vasospasm

Indexed keywords

KETAMINE; PAPAVERINE;

ANESTHESIA; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTICONVULSANT ACTIVITY; ARTICLE; BLOOD FLOW; BRAIN VASOSPASM; CONTROLLED STUDY; DRUG EFFECT; ELECTROCORTICOGRAPHY; ENDOVASCULAR SURGERY; EPILEPTIC DISCHARGE; NONHUMAN; PRIORITY JOURNAL; RAT; SEIZURE; SPRAGUE DAWLEY RAT;

ANALGESICS; ANIMALS; DOSE-RESPONSE RELATIONSHIP, DRUG; ELECTROENCEPHALOGRAPHY; FRONTAL LOBE; INJECTIONS, INTRA-ARTERIAL; KETAMINE; MALE; PAPAVERINE; RANDOM ALLOCATION; RATS; RATS, SPRAGUE-DAWLEY; TIME FACTORS; VASODILATOR AGENTS;

EID: 52949111483     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neulet.2008.08.071     Document Type: Article

References (31)

1. Andaluz N., Tomsick T.A., Tew Jr. J.M., van Loveren H.R., Yeh H.S., and Zuccarello M. Indications for endovascular therapy for refractory vasospasm after aneurismal subarachnoid hemorrhage: experience at the University of Cincinnati. Surg. Neurol. 58 (2002) 131-138
2. Bosnak M., Ayyildiz M., Yildirim M., and Agar E. The role of nitric oxide in the anticonvulsant effects of pyridoxine on penicillin-induced epileptiform activity in rats. Epilepsy Res. 76 (2007) 49-59
3. Carhuapoma J.R., Qureshi A.I., Tamargo R.J., Mathis J.M., and Hanley D.F. Intra-arterial papaverine-induced seizures: case report and review of the literature. Surg. Neurol. 56 (2001) 159-163
4. Clouston J.E., Numaguchi Y., Zoarski G.H., Aldrich E.F., Simard J.M., and Zitnay K.M. Intra-arterial papaverine infusion for cerebral vasospasm after subarachnoid hemorrhage. AJNR 16 (1995) 27-38
5. Czuczwar S., Janusz W., Wamil A., and Kleinrok Z. Inhibition of aminophylline-induced convulsions in mice by antiepileptic drugs and other agents. Eur. J. Pharmacol. 144 (1987) 309-315
6. Dragunow M., and Goddard G.V. Adenosine modulation of amygdale kindling. Exp. Neurol. 84 (1984) 654-665
7. Dragunow M., Goddard G.V., and Laverty R. Is adenosine an endogenous anticonvulsant?. Epilepsia 26 (1985) 480-487
8. Dragunow M. Time-dependent effects of papaverine on electrically induced seizures in rats. Neurosci. Lett. 74 (1987) 320-324
9. Fandino J., Kaku Y., Schuknecht B., Valavanis A., and Yonekawa Y. Improvement of cerebral oxygenation patterns and metabolic validation of superselective intraarterial infusion of papaverine for the treatment of cerebral vasospasm. J. Neurosurg. 89 (1998) 93-100
10. Firlik K.S., Kaufmann A.M., Firlik A.D., Jungreis C.A., and Yonas H. Intra-arterial papaverine for the treatment of cerebral vasospasm following aneurismal subarachnoid hemorrhage. Surg. Neurol. 51 (1999) 66-74
11. Hoh B.L., and Ogilvy C.S. Endovascular treatment of cerebral vasospasm: transluminal balloon angioplasty, intra-arterial papaverine, and intra-arterial nicardipine. Neurosurg. Clin. N. Am. 16 (2005) 501-516
12. International Federation of Societies for Clinical Neurophysiology. A glossary of terms most commonly used by clinical electroencephalographers. Electroencephalogr. Clin. Neurophysiol. 37 (1974) 538-548
13. Joshi S., Hashimoto T., Ostapkovich N., Pile-Spellman J., Duong D.H., Hacien-Bey L., Marshall R.S., James D.J., and Young W.L. Effect of intracarotid papaverine on human cerebral blood flow and vascular resistance during acute hemispheric arterial hypotension. J. Neurosurg. Anesthesiol. 13 (2001) 146-151
14. Kaku Y., Yonekawa Y., Tsukahara T., and Kazekawa K. Superselective intra-arterial infusion of papaverine for the treatment of cerebral vasospasm after subarachnoid hemorrhage. J. Neurosurg. 77 (1992) 842-847
15. Kassell N.F., Helm G., Simmons N., Phillips C.D., and Cail W.S. Treatment of cerebral vasospasm with intraarterial papaverine. J. Neurosurg. 77 (1992) 848-852
16. Liu J.K., Tenner M.S., Gottfried O.N., Stevens E.A., Rosenow J.M., Madan N., MacDonald J.D., Kestle J.R.W., and Couldwell W.T. Efficacy of multiple intraarterial papaverine infusions for improvement in cerebral circulation time in patients with recurrent cerebral vasospasm. J. Neurosurg. 100 (2004) 414-421
17. Marks M.P., Steinberg G.K., and Lane B. Intraarterial papaverine for the treatment of vasospasm. AJNR 14 (1993) 822-826
18. Mathis J.M., DeNardo A., Jensen M.E., Scott J., and Dion J.E. Transient neurologic events associated with intraarterial papaverine infusion for subarachnoid hemorrhage-induced vasospasm. AJNR 15 (1994) 1671-1674
19. Mathis J.M., Jensen M.E., and Dion J.E. Technical considerations on intra-arterial papaverine hydrochloride for cerebral vasospasm. Neuroradiology 39 (1997) 90-98
20. Midzyanovskaya I.S., Salonin D.V., Bosnyakova D.Y., Kuznetsova G.D., and van Luijtelaar E.L. The multiple effects of ketamine on electroencephalographic activity and behavior in WAG/Rij rats, Pharmacology. Biochem. Behav. 79 (2004) 83-91
21. Milburn J.M., Moran C.J., Cross III D.T., Diringer M.N., Pilgram T.K., and Dacey Jr. R.G. Effect of intraarterial papaverine on cerebral circulation time. AJNR 18 (1997) 1081-1085
22. Modica P.A., Tempelhoff R., and White P.F. Pro-and anticonvulsant effects of anesthetics (Part II). Anesth. Analg. 70 (1990) 433-444
23. Morgan M.K., Jonker B., Finfer S., Harrington T., and Dorsch N.W.C. Aggressive management of aneurysmal subarachnoid haemorrhage based on a papaverine angioplasty protocol. J. Clin. Neurosci. 7 (2000) 305-308
24. Nakao S., Arai T., Mori K., Yasuhara O., Tooyama I., and Kimura H. High dose ketamine does not induce c-Fos protein expression in rat hippocampus. Neurosci. Lett. 151 (1993) 33-36
25. Numaguchi Y., Zoarski G.H., Clouston J.E., Zagardo M.T., Simard J.M., Aldrich E.F., Sloan M.A., Maurer P.K., and Okawara S.H. Repeat intra-arterial papaverine for recurrent cerebral vasospasm after subarachnoid haemorrhage. Neuroradiology 39 (1997) 751-759
26. Numaguchi Y., and Zoarski G.H. Intra-arterial papaverine treatment for cerebral vasospasm: our experience and review of the literature. Neurol. Med. Chir. (Tokyo) 38 (1998) 189-195
27. Sawada M., Hashimoto N., Tsukahara T., Nishi S., Kaku Y., and Yoshimura S. Effectiveness of intra-arterially infused papaverine solutions of various concentrations for the treatment of cerebral vasospasm. Acta Neurochir. (Wien) 139 (1997) 706-711
28. Smith W.S., Dowd C.F., Johnston C., Ko N.U., DeArmond J., Dillon W.P., Setty D., Lawton M.T., Young W.L., Higashida R.T., and Halbach V.V. Neurotoxicity of intra-arterial papaverine preserved with chlorobutanol used for the treatment of cerebral vasospasm after aneurismal subarachnoid hemorrhage. Stroke 35 (2004) 2518-2522
29. Ramzan I. Proconvulsant effects of papaverine on theophiline-induced seizures in rats. Clin. Exp. Pharmacol. Physiol. 16 (1989) 425-427
30. Terada T., Kinoshita Y., Yokote H., Tsuura M., Nakai K., Itakura T., Hyotani G., Kuriyama T., Naka Y., and Kido T. The effect of endovascular therapy for cerebral arterial spasm, its limitation and pitfalls. Acta Neurochir. (Wien) 139 (1997) 227-234
31. Tsurushima H., Kamezaki T., Nagatomo Y., Hyodo A., and Nose T. Complications associated with intraarterial administration of papaverine for vasospasm following subarachnoid hemorrhage-two case reports. Neurol. Med. Chir. (Tokyo) 40 (2000) 112-115